List of Figures:
Figure 3-1: Patient Monitoring System Demand (Billion US$), 2010-2014
Figure 4-1: Medical Imaging Equipment Demand (Billion US$), 2010-2014
Figure 4-2: IVD Products Demand (Billion US$), 2010-2014
Figure 4-3: IVD Products Demand by Clinical Segment (%), 2010 & 2014
Figure 4-4: Clinical Chemistry Products Demand (Billion US$), 2010-2014
Figure 4-5: Molecular Diagnostic Products Demand (Billion US$), 2010-2014
Figure 4-6: Blood Testing Products Demand (Billion US$), 2010-2014
Figure 4-7: Immunoassay Products Demand (Billion US$), 2010-2014
Figure 4-8: Number of Diabetic Population (Million), 2010 & 2030
Figure 4-9: Blood Glucose Monitoring Market (Billion US$), 2010-2014
Figure 4-10: Cardiovascular Diagnostics Market (Billion US$), 2010-2014
Figure 4-11: Cancer Diagnostics Market (Billion US$), 2010-2014
Figure 5-1: Breakup of Clinical Labs by Type (%), 2010
Figure 5-2: Clinical Lab Services Market (Billion US$), 2010-2014
List of Tables:
Table 3-1: Life Expectancy and Prevalence of Diseases by Countries
Table 4-1: List of HIV Diagnostic Products
Table 6-1: Roche Holding Ltd - Strengths & Weaknesses
Table 6-2: Johnson & Johnson- Strengths & Weaknesses
Table 6-3: BioMérieux S.A. - Strengths & Weaknesses
Table 6-4: Siemens AG - Strengths & Weaknesses
Table 6-5: Becton, Dickinson and Company - Strengths & Weaknesses
Table 6-6: Abbott Laboratories - Strengths & Weaknesses
Table 6-7: Beckman Coulter, Inc - Strengths & Weaknesses
Table 6-8: Gen-Probe Inc. - Strengths & Weaknesses
Table 6-9: Quest Diagnostics Inc. - Strengths & Weaknesses
Table 6-10: Laboratory Corporation of America Holdings - Strengths & Weaknesses
Table 6-11: Genomic Health Inc. - Strengths & Weaknesses